Radiotherapy enhances responses of lung cancer to CTLA-4 blockade
Abstract Formenti et al. have recently reported the clinical outcomes and translational readouts of a trial of the anti-CTLA-4 inhibitor, ipilimumab, in combination with palliative radiotherapy in 39 patients with non-small cell lung cancer. A radiological response was seen in 18% of patients and 31...
Shranjeno v:
| Principais autores: | , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BMJ Publishing Group
2019-03-01
|
| Serija: | Journal for ImmunoTherapy of Cancer |
| Teme: | |
| Online dostop: | http://link.springer.com/article/10.1186/s40425-019-0542-z |
| Oznake: |
Brez oznak, prvi označite!
|